Navigation Links
IFX anti-TNF therapy associated with clinical benefit over 5 years in patients with active AS
Date:6/12/2009

ients with this chronic condition."

The 103 AS patients from 6 European countries (Belgium, Finland, France, Germany, the Netherlands and the United Kingdom) recruited to the 96-week open-label EASIC (European

Ankylosing Spondylitis Infliximab Cohort) trial had previously participated in the 2-year randomised controlled trial ASSERT (Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy). The EASIC population consisted of 82.5% men and 17.5% women, with a mean age of 43.5 years. There was no major difference between the EASIC and ASSERT study populations in terms of demographics or age.

Between the two trials, patients had a break from their clinical trial-prescribed treatment regime of 1.30.9 years, during which they were treated according to local clinical practice. According to differences in such local standards, one group of patients continued to receive IFX (group 2, n=89, 83 of whom went forward for analysis) and one group did not (group 1, n=14 all analysed). Of the latter, group 1a had relapsed (BASDAI >4 and physician global VAS >4) (n=9) and group 1b were in remission (n=5). Interestingly, all these relapsed patients (group 1a), who had not been treated with IFX during the period between the trials, flared at the time of start of EASIC.

During EASIC, all patients (except for those who had remained in remission) were continuously treated with IFX 5mg/kg (mean dosage) at intervals of 6-8 weeks (at the discretion of the investigator, according to local clinical practice). The patients in group 2 (who had also continuously received IFX between the trials) and completed the trial (n=76) showed significant improvement at week 96 compared to the ASSERT trial baseline data in a number of assessments:

  • BASDAI (Bath AS Disease Activity Index): 6.4 at ASSERT baseline vs 2.5 at week 96 of EASIC (p<0.001)
  • BASFI (Bath AS Functional Index): 5.9 vs 3.1 (p<0.001)
  • BASMI (Bath AS Metrology Index): 4.
    '/>"/>

Contact: Rory Berrie
eularpressoffice@uk.cohnwolfe.com
44-789-438-6425
European League Against Rheumatism
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. SIMPONI(TM) (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
2. 30 percent RA patients refractory to anti-TNFs achieve disease remission with tocilizumab plus metho
3. Adalimumab therapy effective in AS, RA and PsA patients refractory to other anti-TNF therapies
4. Study shows promise for new cancer-stopping therapy
5. MORE WOMEN SHUN HORMONE REPLACEMENT THERAPY Garden of Life Offers a Natural Solution with Oceans 3&#8482; Healthy Hormones&#8482;
6. Hormone therapy may confer more aggressive properties to prostate tumors
7. Pharmacy Organizations Brief Congress on Medication Therapy Management
8. Vaporized viral vector shows promise in anti-cancer gene therapy
9. Death rates same for diabetes and heart disease patients receiving drug therapy or surgery
10. Cant Sleep? Try Online Therapy
11. Astellas Adds CNS Therapy Area Leader to Global R&D Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... WASHINGTON, Dec. 15 Our Lady of Lourdes ... New Jersey hospitals, has agreed to pay the United ... defrauded Medicare, the Justice Department announced today. The two ... in Camden, N.J., and Lourdes Medical Center of Burlington ... a defendant in a suit brought by a whistleblower, ...
(Date:12/15/2009)... really been in trouble, expert says , , TUESDAY, Dec. ... H1N1 swine flu has revealed serious flaws in the ... new report says. , The report, prepared by the ... Foundation, also finds the dire economy has strained the ... outbreak is the latest in a series of reminders ...
(Date:12/15/2009)... education program will train advocates to be leaders ... Project developed with support from experts in online ... ,, WASHINGTON, Dec. 15 ... are accepting applications for the first-ever "Malaria Griots" ... and educate participants to become leaders in the ...
(Date:12/15/2009)... Patient advocate Betsy McCaughey, Ph.D., will ... "it doesn,t matter whether there,s a public option. The ... option - give government authority over how your doctor ... social agenda by shifting billions of dollars from Medicare ... and local politicians." ,, Betsy McCaughey is ...
(Date:12/15/2009)... of 30 Individuals Charged in Miami, Detroit and ... Billing to Medicare ,, WASHINGTON, Dec. ... in three cities for their alleged roles in ... false Medicare claims as part of the continuing ... of Health and Human Services (HHS) Secretary Kathleen ...
Breaking Medicine News(10 mins):Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 3Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 4Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 5
... lip service reform, ARLINGTON, Va., Feb. 7 ... Stanley, Esq., Assistant Director, Treatment,Advocacy Center:, The ... have been a wake-up,call to legislators to provide ... the General Assembly is considering little more than,lip-service ...
... Calif., Feb. 7 The Nebraska Medical,Center, ... Omaha, Neb., has,been recognized for a third ... Power and Associates Distinguished Hospital Program(SM). This,distinction ... Medical Center,to provide its patients with "An ...
... available in German . , More room ... which the Deutsche Forschungsgemeinschaft (German Research Foundation, DFG) has ... Projects, Germanys largest research funding organisation will support especially ... January, the DFG Joint Committee approved this new type ...
... The Institute for Operations Research and the Management Sciences ... the 2008 Franz Edelman Award for Achievement in Operations ... DC this year. , Reflecting the wide-ranging ... 500 company, three teams from Western Europe, and two ...
... Portions of Game Checks to Benefit the Kay Yow/WBCA ... ... referees will,storm women,s basketball courts February 8-17 to raise funds for cancer,research ... III; NJCAA Division I, II & III; NAIA; and high school referees ...
... -- Lotus Pharmaceuticals,Inc. (OTC Bulletin Board: LTUS) ... the People,s Republic of China ("PRC"), today,announced ... wholly owned,subsidiary of Lotus, has implemented cost ... production costs by approximately 50%., The ...
Other Medicine News:Health News:Virginia Legislators Fail to Act Responsibly in Wake of Virginia Tech 2Health News:J.D. Power and Associates Reports: The Nebraska Medical Center Recognized for Providing an Outstanding Inpatient Experience for a Third Consecutive Year, and for Providing an Outstanding Cardiovascular Experience 2Health News:J.D. Power and Associates Reports: The Nebraska Medical Center Recognized for Providing an Outstanding Inpatient Experience for a Third Consecutive Year, and for Providing an Outstanding Cardiovascular Experience 3Health News:DFG introduces Reinhart Koselleck Projects 2Health News:World's best analysts compete to win Edelman Prize in operations research and analytics 2Health News:Thousands of Women's Basketball Referees to Wear Pink Whistles February 8-17; 'Calling For a Cure' Program to Raise Funds for Cancer Research 2Health News:Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies 2
(Date:12/15/2009)... Immucor, Inc. (Nasdaq: BLUD ), a global leader ... industry, today announced that it will release its fiscal ... after the market close. The Company will host a ... a.m. (Eastern Time) to discuss the results. ... call by dialing 1-888-324-9321 (Passcode: BLUD). Investors can also ...
(Date:12/15/2009)... -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) ... 2009 special dividend payment of $1.67 per share to ... 1, 2009. With this payment, distributions to stockholders ... per share. In January 2010, the Company will ... the Company,s 2009 cash distributions and the allocation between ...
(Date:12/15/2009)... Pa., Dec. 15 West Pharmaceutical Services, Inc. ... Board of Directors has approved payment of the first-quarter ... will be paid on February 3, 2010 to shareholders ... About West ,, West is a global manufacturer ... stoppers and seals for vials, and closures and disposable ...
Breaking Medicine Technology:PDL BioPharma Completes December 15 Special Dividend Payment 2PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 1PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 2PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 3PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum 59729 4Lubris Biomodels Report on Potential New Therapy for Osteoarthritis 14521 1Lubris Biomodels Report on Potential New Therapy for Osteoarthritis 14521 2NovaBay Pharmaceuticals Expands Management Team 3B Names Mark Anderson Ph D as Chief Scientific Officer 5549 1NovaBay Pharmaceuticals Expands Management Team 3B Names Mark Anderson Ph D as Chief Scientific Officer 5549 2NovaBay Pharmaceuticals Expands Management Team 3B Names Mark Anderson Ph D as Chief Scientific Officer 5549 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: